儿童局灶节段性肾小球硬化新遗传风险因素的鉴定:来自慢性肾脏病儿童(CKiD)队列的结果
本研究对CKiD队列中140例非洲裔美国慢性肾脏病患儿(含32例经活检证实的原发性局灶节段性肾小球硬化)进行病例对照遗传关联研究,检测超过68万个单核苷酸多态性。发现14个独立位点的169个单核苷酸多态性与局灶节段性肾小球硬化显著相关,包括APOL1、ALMS1和FGFR4等既往在成人中报道的基因,以及GRB2和ITGB1等新基因,并提示免疫应答和抗原呈递在儿童局灶节段性肾小球硬化中可能起重要作用。
要点
- 在非洲裔美国患儿中,APOL1变异与局灶节段性肾小球硬化强相关(P=8.6×10-7;OR 25.8)。
- ALMS1变异在病例组频率为13.0%,对照组为0%。
- HLA-DRB1*11:01与儿童局灶节段性肾小球硬化相关(P=6.1×10-3;OR 4.5)。
核心结论
- 本研究识别了与儿童原发性局灶节段性肾小球硬化功能相关的风险因素,并提示免疫调节在该病中的重要性,有助于更好地描述其分子病理生理机制。
研究设计与样本
- 前瞻性队列中的病例对照遗传关联研究,纳入CKiD队列140例非洲裔美国慢性肾脏病患儿,其中32例为经活检证实的原发性局灶节段性肾小球硬化病例。
主要发现
- 全基因组关联研究显示,来自14个独立位点的169个单核苷酸多态性与局灶节段性肾小球硬化显著相关(错误发现率<5%)。
- APOL1基因变异与局灶节段性肾小球硬化相关(P=8.6×10-7;OR 25.8,95%CI 7.1-94.0)。
- ALMS1基因变异在局灶节段性肾小球硬化病例中频率为13.0%,在对照中为0%(P=1.3×10-7)。
- FGFR4基因变异与局灶节段性肾小球硬化相关(P=4.3×10-6;OR 24.8,95%CI 6.3-97.7)。
- PTPRJ(CD148)变异与局灶节段性肾小球硬化相关(P=3.5×10-7),HLA-DRB1*11:01亦相关(P=6.1×10-3;OR 4.5,95%CI 1.5-13.0),信号通路富集分析P=1.3×10-6。
临床怎么用
- 原文未据此给出推荐。
局限性
- 样本量有限,且无现成基因组数据的独立重复队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Focal segmental glomerulosclerosis (FSGS) is a major cause of pediatric nephrotic syndrome, and African Americans exhibit an increased risk for developing FSGS compared with other populations. Predisposing genetic factors have previously been described in adults. Here we performed genomic screening of primary FSGS in a pediatric African American population. STUDY DESIGN: Prospective cohort with case-control genetic association study design. SETTING & PARTICIPANTS: 140 African American children with chronic kidney disease from the Chronic Kidney Disease in Children (CKiD) cohort, including 32 cases with FSGS. PREDICTORS: Over 680,000 common single-nucleotide polymorphisms (SNPs) were tested for association. We also ran a pathway enrichment analysis and a human leucocyte antigen (HLA)-focused association study. OUTCOME: Primary biopsy-proven pediatric FSGS. ANALYTICAL APPROACH: Multivariate logistic regression models. RESULTS: The genome-wide association study revealed 169 SNPs from 14 independent loci significantly associated with FSGS (false discovery rate [FDR]<5%). We observed notable signals for genetic variants within the APOL1 (P=8.6×10-7; OR, 25.8 [95% CI, 7.1-94.0]), ALMS1 (P=1.3×10-7; 13.0% in FSGS cases vs 0% in controls), and FGFR4 (P=4.3×10-6; OR, 24.8 [95% CI, 6.3-97.7]) genes, all of which had previously been associated with adult FSGS, kidney function, or chronic kidney disease. We also highlighted novel, functionally relevant genes, including GRB2 (which encodes a slit diaphragm protein promoting podocyte structure through actin polymerization) and ITGB1 (which is linked to renal injuries). Our results suggest a major role for immune responses and antigen presentation in pediatric FSGS through (1) associations with SNPs in PTPRJ (or CD148, P=3.5×10-7), which plays a role in T-cell receptor signaling, (2) HLA-DRB1∗11:01 association (P=6.1×10-3; OR, 4.5 [95% CI, 1.5-13.0]), and (3) signaling pathway enrichment (P=1.3×10-6). LIMITATIONS: Sample size and no independent replication cohort with genomic data readily available. CONCLUSIONS: Our genetic study has identified functionally relevant risk factors and the importance of immune regulation for pediatric primary FSGS, which contributes to a better description of its molecular pathophysiological mechanisms. PLAIN-LANGUAGE SUMMARY: We assessed the genetic risk factors for primary focal segmental glomerulosclerosis (FSGS) by simultaneously testing over 680,000 genetic markers spread across the genome in 140 children, including 32 with FSGS lesions. Fourteen independent genetic regions were significantly associated with pediatric FSGS, including APOL1 and ALMS1-NAT8, which were previously found to be associated with FSGS and chronic kidney diseases in adults. Novel genes with relevant biological functions were also highlighted, such as GRB2 and FGFR4, which play a role in the kidney filtration barrier and in kidney cell differentiation, respectively. Finally, we revealed the importance of immune regulation in pediatric FSGS through associations involving cell surface proteins presenting antigens to the immune system and interacting with T-cell receptors.
引用
- Durand A, Winkler CA, Vince N, et al. Identification of Novel Genetic Risk Factors for Focal Segmental Glomerulosclerosis in Children: Results From the Chronic Kidney Disease in Children (CKiD) Cohort. Am J Kidney Dis. 2023. PMID: 36623684. doi:10.1053/j.ajkd.2022.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。